Debriefing to placebo allocation: A phenomenological study of participants’ experiences in a randomized clinical trial. Conference paper presented at ECIM 2010.
Debriefing to placebo allocation: A phenomenological study of participants’ experiences in a randomized clinical trial. Conference paper presented at ECIM 2010.
Question: Concealment is integral to placebo-controlled clinical trials and insures that participants remain blind to whether they are receiving real (verum) or dummy (placebo) treatment. While participants are routinely informed about and consent to be randomised to verum or placebo, they are typically never told which treatment they actually received: they are not debriefed to treatment allocation. Participants’ experiences of this aspect of trials have not been well-described.
Methods: We therefore conducted an idiographic phenomenological study of four participants’ experiences of being blinded to and then debriefed to placebo allocation in a placebo-controlled clinical trial (conducted in the USA). Four participants in a trial of acupuncture for IBS were interviewed before, during, and after receiving a course of placebo treatments over 6 weeks. During the final interview they were debriefed to placebo allocation.
Results: Each participant's experiences of being blinded to and then debriefed to placebo allocation are described in depth using a phenomenological approach based on the Sheffield School. All four thought they had received real acupuncture, and based their belief on a combination of embodied experiences during and after treatments, and their perceptions of their acupuncturists. They were all surprised to be told they had placebo, and did not unquestionably accept this news. Instead, they developed revised explanations that reconciled their lived experiences (of real acupuncture) with the conflicting news (of placebo acupuncture) from the interviewer.
Conclusions: Our participants’ experiences of blinding and debriefing were embodied, related to their goals in undertaking the study, and social – embedded in trusting and valued relationships with acupuncturists, told to others outside the study, and described to an interviewer. This work suggests that debriefing to placebo allocation can and should be managed sensitively to facilitate positive outcomes for participants: further research should focus on developing best practice in this area.
199-199
Bishop, F.
1f5429c5-325f-4ac4-aae3-6ba85d079928
Jacobsen, E.
e139e836-7501-4d8c-a8a2-0cef22301261
Shaw, J.
597595f2-31f5-4289-aa40-3dbec3c92778
Kaptchuk, T.
2f00a336-47cc-408c-998a-c85d8f7e3feb
December 2010
Bishop, F.
1f5429c5-325f-4ac4-aae3-6ba85d079928
Jacobsen, E.
e139e836-7501-4d8c-a8a2-0cef22301261
Shaw, J.
597595f2-31f5-4289-aa40-3dbec3c92778
Kaptchuk, T.
2f00a336-47cc-408c-998a-c85d8f7e3feb
Bishop, F., Jacobsen, E., Shaw, J. and Kaptchuk, T.
(2010)
Debriefing to placebo allocation: A phenomenological study of participants’ experiences in a randomized clinical trial. Conference paper presented at ECIM 2010.
European Journal of Integrative Medicine, 2 (4), .
(doi:10.1016/j.eujim.2010.09.058).
Abstract
Question: Concealment is integral to placebo-controlled clinical trials and insures that participants remain blind to whether they are receiving real (verum) or dummy (placebo) treatment. While participants are routinely informed about and consent to be randomised to verum or placebo, they are typically never told which treatment they actually received: they are not debriefed to treatment allocation. Participants’ experiences of this aspect of trials have not been well-described.
Methods: We therefore conducted an idiographic phenomenological study of four participants’ experiences of being blinded to and then debriefed to placebo allocation in a placebo-controlled clinical trial (conducted in the USA). Four participants in a trial of acupuncture for IBS were interviewed before, during, and after receiving a course of placebo treatments over 6 weeks. During the final interview they were debriefed to placebo allocation.
Results: Each participant's experiences of being blinded to and then debriefed to placebo allocation are described in depth using a phenomenological approach based on the Sheffield School. All four thought they had received real acupuncture, and based their belief on a combination of embodied experiences during and after treatments, and their perceptions of their acupuncturists. They were all surprised to be told they had placebo, and did not unquestionably accept this news. Instead, they developed revised explanations that reconciled their lived experiences (of real acupuncture) with the conflicting news (of placebo acupuncture) from the interviewer.
Conclusions: Our participants’ experiences of blinding and debriefing were embodied, related to their goals in undertaking the study, and social – embedded in trusting and valued relationships with acupuncturists, told to others outside the study, and described to an interviewer. This work suggests that debriefing to placebo allocation can and should be managed sensitively to facilitate positive outcomes for participants: further research should focus on developing best practice in this area.
This record has no associated files available for download.
More information
Published date: December 2010
Additional Information:
Presented at the 3rd European Congress on Integrative Medicine, Berlin
Identifiers
Local EPrints ID: 176159
URI: http://eprints.soton.ac.uk/id/eprint/176159
ISSN: 1876-3820
PURE UUID: 1d3f956a-d37b-4996-8900-b05fe642069a
Catalogue record
Date deposited: 07 Mar 2011 16:19
Last modified: 14 Mar 2024 02:47
Export record
Altmetrics
Contributors
Author:
E. Jacobsen
Author:
J. Shaw
Author:
T. Kaptchuk
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics